Edition:
United Kingdom

I'rom Group Co Ltd (2372.T)

2372.T on Tokyo Stock Exchange

1,575JPY
24 May 2019
Change (% chg)

¥-22 (-1.38%)
Prev Close
¥1,597
Open
¥1,588
Day's High
¥1,596
Day's Low
¥1,559
Volume
189,700
Avg. Vol
283,362
52-wk High
¥2,479
52-wk Low
¥1,370

Latest Key Developments (Source: Significant Developments)

I'rom Group Co Ltd Says To Buy Back Up To 1.12 Percent Of Own Shares Worth 200 Million Yen Through March 29
Tuesday, 26 Feb 2019 

I'rom Group Co Ltd <2372.T>::I'ROM GROUP CO LTD SAYS TO BUY BACK UP TO 1.12 PERCENT OF OWN SHARES WORTH 200 MILLION YEN THROUGH MARCH 29.  Full Article

I'rom Group unit concludes iPS cell generation technology licensing agreement with Evotec International GmbH
Wednesday, 16 May 2018 

May 16 (Reuters) - I'rom Group Co Ltd <2372.T>:Says its unit ID Pharma Co., Ltd. concluded an iPS cell generation technology related licensing agreement with Germany company Evotec International GmbH .Says its unit will receive upfront payment and annual royalty from Evotec International GmbH .  Full Article

I'rom Group to set up unit in Hong Kong to management and support co's business in China
Monday, 29 Jan 2018 

Jan 29 (Reuters) - I'rom Group Co Ltd <2372.T>:Says it will set up a Hong Kong-based wholly owned unit, I’ROM LIMITED in February, to management and support the company's business in China .Says the unit will be capitalized at HK$100,000 (about 1.5 million yen).  Full Article

I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co's wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc.  Full Article

I'rom Group says business and capital alliance with OKWAVE unit
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co signs business and capital alliance agreement with OKWAVE <<<3808.NG>>> unit OKEIOS, which is mainly engaged in medical information handling systems related design, development and sales .Says co plans to acquire shares of OKEIOS.  Full Article

I'rom Group fully acquires CMAX Clinical Research Pty for A$6.2 mln
Wednesday, 23 Aug 2017 

Aug 23 (Reuters) - I'rom Group Co Ltd <2372.T>:* Says it fully acquired 61 percent owned CMAX Clinical Research Pty Ltd for A$6.2 million from IDT Australia Limited on Aug. 23 .  Full Article

I'rom Group unit ID Pharma concludes iPS cell generation technology licensing agreement with UK-based Axol Bioscience
Tuesday, 11 Jul 2017 

July 11 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co's wholly owned unit, ID Pharma, concluded an iPS cell generation technology licensing agreement with UK-based Axol Bioscience Ltd .Says unit grants non-exclusive rights of iPS cell related research, sales and service and sublicense rights to Axol Bioscience Ltd .Says unit will receive upfront payments, iPS cell sales and service related income and royalty from Axol Bioscience Ltd .  Full Article